According to internet information statistics, the amount of data generated globally is expected to exceed 175ZB this year, ...
New Delhi, September 4, 2025 (ANI): After the 56th GST Council meeting, Union Finance Minister Nirmala Sitharaman said “Reduction from 28 % to 18%- Air conditioning machines, TVs which are over 32 ...
The Nifty 50 recorded its steepest intraday drop in three months, falling 1.02% to 24,712 in Tuesday's trade as investor sentiment soured after the US Department of Homeland Security confirmed that ...
Amlitelimab, dosed every four weeks or every 12 weeks, demonstrated statistically significant and clinically meaningful efficacy in skin clearance and disease severity compared to placebo at Week 24, ...
In the latest trading session, VALE S.A. (VALE) closed at $10.17, marking a -1.07% move from the previous day. The stock's performance was behind the S&P 500's daily loss of 0.69%. Elsewhere, the Dow ...
Emerging-market currencies gained on Thursday, rebounding after two days of declines, as US data showed a resilient economy and ahead of a key inflation report in the world’s largest economy. The ...
Enlicitide is the first oral PCSK9 inhibitor to demonstrate statistically significant and clinically meaningful reductions in LDL-C compared to placebo in Phase 3 trials RAHWAY, N.J.--(BUSINESS WIRE)- ...
Positive results from the global COAST 1 phase 3 study (clinical study identifier: NCT06130566) showed that amlitelimab, a fully human non-T cell depleting monoclonal antibody that targets OX40-ligand ...
A survey shows employers expect a sharp increase in benefit costs for next year, and many will want workers to shoulder more of the burden. By Reed Abelson Employees of large and small companies are ...
Community driven content discussing all aspects of software development from DevOps to design patterns. There are a number of different ways to customize your development environment, but the global ...
Regeneron has reported a phase 3 win in generalized myasthenia gravis (gMG), positioning the pharma to file for FDA approval of its siRNA candidate in the increasingly competitive neuromuscular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback